Form 8-K - Current report:
SEC Accession No. 0001493152-25-017223
Filing Date
2025-10-07
Accepted
2025-10-07 09:00:34
Documents
15
Period of Report
2025-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45137
2 EX-2.1 ex2-1.htm EX-2.1 315753
3 GRAPHIC form8-k_001.jpg GRAPHIC 13709
  Complete submission text file 0001493152-25-017223.txt   658622

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bgms-20251006.xsd EX-101.SCH 3749
5 XBRL DEFINITION FILE bgms-20251006_def.xml EX-101.DEF 26585
6 XBRL LABEL FILE bgms-20251006_lab.xml EX-101.LAB 36613
7 XBRL PRESENTATION FILE bgms-20251006_pre.xml EX-101.PRE 25209
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5748
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Bio Green Med Solution, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 251378338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)